STUDY OF ASSOCIATION OF STAGE WITH RESPONSE IN A PATIENT RECEIVING  CONCURRENT CHEMO RADIOTHERAPY WITH 3 WEEKLY DOCETAXEL 45  MG/MT2 AND CISPLATIN 60 MG/MT2 IN LOCALLY ADVANCED TONGUE  CARCINOMA

Nivedita Verma, Rajeev Ratan Jain, Umesh Dewangan, Manjula Beck , Vivek Choudhary , Pradeep Chandrakar , Rahul Swaroop Singh, Vikram Bali Rathore, Afreen Shams

STUDY OF ASSOCIATION OF STAGE WITH RESPONSE IN A PATIENT RECEIVING CONCURRENT CHEMO RADIOTHERAPY WITH 3 WEEKLY DOCETAXEL 45 MG/MT2 AND CISPLATIN 60 MG/MT2 IN LOCALLY ADVANCED TONGUE CARCINOMA

Authors

Nivedita Verma, Rajeev Ratan Jain, Umesh Dewangan, Manjula Beck , Vivek Choudhary , Pradeep Chandrakar , Rahul Swaroop Singh, Vikram Bali Rathore, Afreen Shams

Keywords:

Stage, Response, concurrent chemo radiotherapy Locally Advanced Tongue Carcinoma

Abstract

Background: Head and neck carcinoma is a heterogeneous disease, encompassing a varietyof tumors that originate in the lip, oral cavity, hypopharynx, oropharynx Naso-pharynx, orlarynx.

References

Mathur P, Sathish kumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S,Nallasamy V, John A, Narasimhan S, Roselind FS, ICMR-NCDIR-NCRP Investigator Group. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Global oncology.2020 Jul;6:1063-75.

Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nature reviews cancer. 2011 Jan; 11(1):9-22.

Downloads

Published

2025-09-16

How to Cite

Nivedita Verma, Rajeev Ratan Jain, Umesh Dewangan, Manjula Beck , Vivek Choudhary , Pradeep Chandrakar , Rahul Swaroop Singh, Vikram Bali Rathore, Afreen Shams. (2025). STUDY OF ASSOCIATION OF STAGE WITH RESPONSE IN A PATIENT RECEIVING CONCURRENT CHEMO RADIOTHERAPY WITH 3 WEEKLY DOCETAXEL 45 MG/MT2 AND CISPLATIN 60 MG/MT2 IN LOCALLY ADVANCED TONGUE CARCINOMA . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 1922–1933. Retrieved from https://ijprt.org/index.php/pub/article/view/988